Belimumab Treatment for IgG4-related Disease

Clinical trial NCT04660565 · UNKNOWN

Trial details

NCT number: NCT04660565
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

IgG4-related Disease

Start date: 2021-01-01
Primary completion: 2022-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.